checkAd

     113  0 Kommentare Entegris Reports Results for Second Quarter of 2023

    Entegris, Inc. (NASDAQ: ENTG), today reported its financial results for the Company’s second quarter ended July 1, 2023. Second-quarter sales were $901.0 million, an increase of 30% from the same quarter last year. Second-quarter GAAP net income was $197.6 million, or $1.31 income per diluted share, which included a $154.8 million of gain on a termination of an alliance agreement, $54.7 million of amortization of intangible assets, $18.4 million of integration costs and $19.4 million of other net costs. Non-GAAP net income was $99.6 million for the second quarter and non-GAAP earnings per diluted share was $0.66. The results for the second quarter of 2022 are shown on a “as reported” basis and not on a “proforma” basis, and as a result do not include CMC Materials’ results.

    Bertrand Loy, Entegris’ president and chief executive officer, said: “Our performance and execution in the second quarter was solid and showcased the resilience of our unit driven model. Sales were down sequentially as expected, but we did see growth in product lines that are of increasing importance to our customers’ technology roadmaps.

    “We have made good progress on key initiatives. The CMC Materials integration is proceeding very well, and we are on track to achieve our $75 million run-rate cost synergy target by the fourth quarter. Debt paydown is a high priority for us and divestitures of non-core assets have been a significant lever to reduce this debt. So far this year, we have entered into definitive agreements for the sale of three businesses, totaling more than $1 billion in proceeds,” he said.

    “While our expectations for an industry recovery in the short term are modest,” Loy said, “we continue to be extremely optimistic about the long-term secular growth of the semiconductor industry. We have strong conviction in the growing importance of our value proposition, our opportunity to grow our content per wafer, and our ability to continue to outperform the market. During the second half of the year, our focus will be on completing the CMC integration and managing our cost structure, while making the necessary investments in our future.”

    Quarterly Financial Results Summary

    (in thousands, except percentages and per share data)

    GAAP Results

    July 1, 2023

    July 2, 2022

    April 1, 2023

    Net sales

    $901,000

    $692,489

    $922,396

    Operating income

    $267,614

    $157,970

    $13,466

    Operating margin - as a % of net sales

    29.7%

    22.8%

    1.5%

    Net income (loss)

    $197,646

    $99,491

    $(88,166)

    Diluted earnings (loss) per common share

    $1.31

    $0.73

    $(0.59)

    Non-GAAP Results

    Non-GAAP adjusted operating income

    $200,917

    $183,039

    $204,772

    Non-GAAP adjusted operating margin - as a % of net sales

    22.3%

    26.4%

    22.2%

    Non-GAAP net income

    $99,605

    $136,816

    $97,782

    Diluted non-GAAP earnings per common share

    $0.66

    $1.00

    $0.65

    Third-Quarter Outlook

    For the third quarter ending September 30, 2023, the Company expects sales of $875 million to $900 million, GAAP net income of $34 million to $42 million and diluted earnings per common share between $0.23 and $0.28. On a non-GAAP basis, the Company expects diluted earnings per common share to range from $0.57 to $0.62, reflecting net income on a non-GAAP basis in the range of $86 million to $94 million. The Company also expects EBITDA of approximately 26% to 27% of sales, for the third quarter of 2023.

    Segment Results

    Lesen Sie auch

    The Company operates in four segments:

    Specialty Chemicals and Engineered Materials (SCEM): SCEM provides advanced materials enabling complex chip designs and improved device electrical performance; including high-performance and high-purity process chemistries, gases and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.

    Microcontamination Control (MC): MC offers advanced filtration solutions that improve customers’ yield, device reliability and cost; by filtering and purifying critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.

    Advanced Materials Handling (AMH): AMH develops solutions that improve customers’ yields by protecting critical materials during manufacturing, transportation, and storage; including products that monitor, protect, transport and deliver critical liquid chemistries, wafers, and other substrates for a broad set of applications in the semiconductor, life sciences and other high-technology industries.

    Advanced Planarization Solutions (APS): APS develops an end-to-end chemical mechanical planarization (CMP) solution and applications expertise delivered through advanced materials and high purity chemicals; including CMP slurries, pads, formulated cleans and other electronic chemicals used in the semiconductor manufacturing processes.

    Second-Quarter Results Conference Call Details

    Entegris will hold a conference call to discuss its results for the second quarter on Thursday, August 3, 2023, at 9:00 a.m. Eastern Time. Participants should dial 800-245-3047 or +1 203-518-9765, referencing confirmation ID: ENTGQ223. Participants are asked to dial in 10 minutes prior to the start of the call. For the live webcast and replay of the call, please Click Here.

    Management’s slide presentation concerning the results for the second quarter will be posted on the Investor Relations section of www.entegris.com in the morning before the call.

    About Entegris

    Entegris is a leading supplier of advanced materials and process solutions for the semiconductor and other high-tech industries. Entegris has approximately 9,000 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. Additional information can be found at www.entegris.com.

    Non-GAAP Information

    The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP). Proforma net sales, adjusted EBITDA, adjusted gross profit, adjusted segment profit, adjusted operating income, non-GAAP net income, non-GAAP adjusted operating margin and diluted non-GAAP earnings per common share, together with related measures thereof, are considered “non-GAAP financial measures” under the rules and regulations of the Securities and Exchange Commission. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company provides supplemental non-GAAP financial measures to better understand and manage its business and believes these measures provide investors and analysts additional and meaningful information for the assessment of the Company’s ongoing results. Management also uses these non-GAAP measures to assist in the evaluation of the performance of its business segments and to make operating decisions. Management believes that the Company’s non-GAAP measures help indicate the Company’s baseline performance before certain gains, losses or other charges that may not be indicative of the Company’s business or future outlook, and that non-GAAP measures offer a more consistent view of business performance. The Company believes the non-GAAP measures aid investors’ overall understanding of the Company’s results by providing a higher degree of transparency for such items and providing a level of disclosure that will help investors generally understand how management plans, measures and evaluates the Company’s business performance. Management believes that the inclusion of non-GAAP measures provides greater consistency in its financial reporting and facilitates investors’ understanding of the Company’s historical operating trends by providing an additional basis for comparisons to prior periods. The reconciliations of GAAP gross profit to adjusted gross profit, GAAP segment profit to adjusted operating income, GAAP net income to adjusted operating income and adjusted EBITDA, GAAP net income and diluted earnings per common share to non-GAAP net income and diluted non-GAAP earnings per common share and GAAP outlook to non-GAAP outlook are included elsewhere in this release.

    Cautionary Note on Forward-Looking Statements

    This news release contains forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward looking statements. These forward-looking statements may include statements about supply chain matters and inflationary pressures; future period guidance or projections; the Company’s performance relative to its markets, including the drivers of such performance; market and technology trends, including the duration and drivers of any growth trends; the development of new products and the success of their introductions; the focus of the Company’s engineering, research and development projects; the Company’s ability to execute on our business strategies, including with respect to Company’s expansion of its manufacturing presence in Taiwan and in Colorado Springs; the Company’s capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the impact of the acquisitions the Company has made and commercial partnerships the Company has established, including the acquisition of CMC Materials, Inc. (now known as CMC Materials LLC) (“CMC Materials”); the closing of any announced divestitures and the termination of strategic partnerships, including the timing thereof; trends relating to the fluctuation of currency exchange rates; future capital and other expenditures, including estimates thereof; the Company’s expected tax rate; the impact, financial or otherwise, of any organizational changes; the impact of accounting pronouncements; quantitative and qualitative disclosures about market risk; and other matters. These forward-looking statements are based on current management expectations and assumptions only as of the date of this Quarterly Report, are not guarantees of future performance and involve substantial risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, but are not limited to, weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for the Company’s products and solutions; the level of, and obligations associated with, the Company’s indebtedness, including the debts incurred in connection with the acquisition of CMC Materials; risks related to the acquisition and integration of CMC Materials, including unanticipated difficulties or expenditures relating thereto; the ability to achieve the anticipated synergies and value-creation contemplated by the acquisition of CMC Materials and the diversion of management time on transaction-related matters; raw material shortages, supply and labor constraints and price increases, inflationary pressures and rising interest rates; operational, political and legal risks of the Company’s international operations; the Company’s dependence on sole source and limited source suppliers; the Company’s ability to meet rapid demand shifts; the Company’s ability to continue technological innovation and introduce new products to meet customers’ rapidly changing requirements; substantial competition; the Company’s concentrated customer base; the Company’s ability to identify, complete and integrate acquisitions, joint ventures, divestitures or other similar transactions; the Company’s ability to consummate pending transactions on a timely basis or at all and the satisfaction of the conditions precedent to consummation of such pending transactions, including the satisfaction of regulatory conditions on the terms expected, at all or in a timely manner; the Company’s ability to effectively implement any organizational changes; the Company’s ability to protect and enforce intellectual property rights; the increasing complexity of certain manufacturing processes; changes in government regulations of the countries in which the Company operates, including the imposition of tariffs, export controls and other trade laws and restrictions and changes to national security and international trade policy, especially as they relate to China; fluctuation of currency exchange rates; fluctuations in the market price of the Company’s stock; and other risk factors and additional information described in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including under the heading “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed on February 23, 2023, and in the Company’s other SEC filings. Except as required under the federal securities laws and the rules and regulations of the SEC, the Company undertakes no obligation to update publicly any forward-looking statements or information contained herein, which speak as of their respective dates.

     

    Entegris, Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations

    (In thousands, except per share data)

    (Unaudited)

     

     

    Three months ended

     

    July 1, 2023

    July 2, 2022

    April 1, 2023

    Net sales

    $901,000

    $692,489

    $922,396

    Cost of sales

    516,834

    382,092

    520,711

    Gross profit

    384,166

    310,397

    401,685

    Selling, general and administrative expenses

    145,596

    90,685

    169,867

    Engineering, research and development expenses

    71,030

    49,248

    71,906

    Amortization of intangible assets

    54,680

    12,494

    57,574

    Goodwill impairment

    88,872

    Gain on termination of alliance agreement

    (154,754)

    Operating income

    267,614

    157,970

    13,466

    Interest expense, net

    78,605

    31,343

    84,821

    Other expense (income), net

    7,724

    9,619

    (4,658)

    Income (loss) before income tax (benefit) expense

    181,285

    117,008

    (66,697)

    Income tax (benefit) expense

    (16,491)

    17,517

    21,469

    Equity in net loss of affiliates

    130

    Net income (loss)

    $197,646

    $99,491

    $(88,166)

     

     

     

     

     

     

     

    Basic earnings (loss) per common share:

    $1.32

    $0.73

    $(0.59)

    Diluted earnings (loss) per common share:

    $1.31

    $0.73

    $(0.59)

     

     

     

     

    Weighted average shares outstanding:

     

     

     

    Basic

    149,825

    135,895

    149,426

    Diluted

    150,837

    136,454

    149,426

     

    Entegris, Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations

    (In thousands, except per share data)

    (Unaudited)

     

     

    Six months ended

     

    July 1, 2023

    July 2, 2022

    Net sales

    $1,823,396

    $1,342,135

    Cost of sales

    1,037,545

    721,918

    Gross profit

    785,851

    620,217

    Selling, general and administrative expenses

    315,463

    177,793

    Engineering, research and development expenses

    142,936

    95,963

    Amortization of intangible assets

    112,254

    25,145

    Goodwill impairment

    88,872

    Gain on termination of alliance agreement

    (154,754)

    Operating income

    281,080

    321,316

    Interest expense, net

    163,426

    44,877

    Other expense, net

    3,066

    14,521

    Income before income tax expense

    114,588

    262,588

    Income tax expense

    4,978

    37,392

    Equity in net loss of affiliates

    130

    Net income

    $109,480

    $225,196

     

     

     

     

     

    Basic earnings per common share:

    $0.73

    $1.66

    Diluted earnings per common share:

    $0.73

    $1.65

     

     

     

    Weighted average shares outstanding:

     

     

    Basic

    149,626

    135,783

    Diluted

    150,609

    136,503

     

    Entegris, Inc. and Subsidiaries

    Condensed Consolidated Balance Sheets

    (In thousands)

    (Unaudited)

     

     

    July 1, 2023

    December 31, 2022

    ASSETS

     

     

    Current assets:

     

     

    Cash, cash equivalents and restricted cash

    $567,017

    $563,439

    Trade accounts and notes receivable, net

    435,973

    535,485

    Inventories, net

    740,351

    812,815

    Deferred tax charges and refundable income taxes

    55,461

    47,618

    Assets held-for-sale

    1,051,947

    246,531

    Other current assets

    117,799

    129,297

    Total current assets

    2,968,548

    2,335,185

    Property, plant and equipment, net

    1,364,760

    1,393,337

    Other assets:

     

     

    Right-of-use assets

    81,048

    94,940

    Goodwill

    3,970,247

    4,408,331

    Intangible assets, net

    1,421,710

    1,841,955

    Deferred tax assets and other noncurrent tax assets

    66,682

    28,867

    Other

    40,029

    36,242

    Total assets

    $9,913,024

    $10,138,857

    LIABILITIES AND EQUITY

     

    Current liabilities

     

     

    Short-term debt, including current portion of long-term debt

    151,965

    Accounts payable

    132,157

    172,488

    Accrued liabilities

    311,784

    328,784

    Liabilities held-for-sale

    115,784

    10,637

    Income tax payable

    86,564

    98,057

    Total current liabilities

    646,289

    761,931

    Long-term debt, excluding current maturities

    5,492,011

    5,632,928

    Long-term lease liability

    69,405

    80,716

    Other liabilities

    353,114

    445,282

    Shareholders’ equity

    3,352,205

    3,218,000

    Total liabilities and equity

    $9,913,024

    $10,138,857

     

    Entegris, Inc. and Subsidiaries

    Condensed Consolidated Statements of Cash Flows

    (In thousands)

    (Unaudited)

     

     

    Three months ended

    Six months ended

     

    July 1, 2023

    July 2, 2022

    July 1, 2023

    July 2, 2022

    Operating activities:

     

     

     

     

    Net income

    $197,646

    $99,491

    $109,480

    $225,196

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

    Depreciation

    43,719

    24,381

    90,494

    48,286

    Amortization

    54,680

    12,494

    112,254

    25,145

    Share-based compensation expense

    11,458

    10,182

    42,136

    19,467

    Loss on extinguishment of debt and modification

    4,482

    7,269

    Impairment of Goodwill

    88,872

    Gain on termination of alliance agreement

    (154,754)

    (154,754)

    Loss on sale of business and held for sale assets

    14,935

    28,577

    Other

    (10,318)

    8,492

    (17,288)

    8,687

    Changes in operating assets and liabilities, net of effects of acquisitions:

     

     

     

     

    Trade accounts and notes receivable

    9,562

    (26,138)

    17,941

    (57,309)

    Inventories

    29,843

    (47,465)

    (5,009)

    (124,941)

    Accounts payable and accrued liabilities

    (43,638)

    49,468

    (23,595)

    27,145

    Income taxes payable, refundable income taxes and noncurrent taxes payable

    (31,437)

    (20,308)

    (15,570)

    (3,548)

    Other

    840

    313

    (1,918)

    6,570

    Net cash provided by operating activities

    127,018

    110,910

    278,889

    174,698

    Investing activities:

     

     

     

     

    Acquisition of property and equipment

    (116,051)

    (107,692)

    (250,043)

    (192,097)

    Proceeds from sale of business

    759

    134,286

    Proceeds from termination of alliance agreement

    169,251

    169,251

    Other

    258

    366

    1,123

    Net cash provided by (used in) investing activities

    54,217

    (107,692)

    53,860

    (190,974)

    Financing activities:

     

     

     

     

    Proceeds from revolving credit facility, short-term debt and long-term debt

    2,527,314

    117,170

    2,606,314

    Payments of revolving credit facility, short-term debt and long-term debt

    (311,501)

    (114,000)

    (428,671)

    (193,000)

    Payments for debt issuance costs

    (3,475)

    (10,579)

    (3,475)

    (10,579)

    Payments for dividends

    (14,980)

    (13,589)

    (30,150)

    (27,484)

    Issuance of common stock

    18,374

    5,598

    36,767

    8,977

    Taxes paid related to net share settlement of equity awards

    (240)

    (200)

    (9,646)

    (16,317)

    Other

    (279)

    375

    (578)

    (587)

    Net cash (used in) provided by financing activities

    (312,101)

    2,394,919

    (318,583)

    2,367,324

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    (11,149)

    (7,638)

    (10,588)

    (10,382)

    (Decrease) increase in cash, cash equivalents and restricted cash

    (142,015)

    2,390,499

    3,578

    2,340,666

    Cash, cash equivalents and restricted cash at beginning of period

    709,032

    352,732

    563,439

    402,565

    Cash, cash equivalents and restricted cash at end of period

    $567,017

    $2,743,231

    $567,017

    $2,743,231

     

    Entegris, Inc. and Subsidiaries

    Segment Information

    (In thousands)

    (Unaudited)

     

     

    Three months ended

     

    Six months ended

    Net sales

    July 1, 2023

    July 2, 2022

    April 1, 2023

     

    July 1, 2023

    July 2, 2022

    Specialty Chemicals and Engineered Materials

    $200,073

    $179,412

    $198,004

     

    $398,077

    $345,188

    Advanced Planarization Solutions

    240,561

    28,317

    250,326

     

    490,887

    58,962

    Microcontamination Control

    283,614

    274,133

    269,297

     

    552,911

    540,770

    Advanced Materials Handling

    190,356

    224,084

    218,853

     

    409,209

    422,197

    Inter-segment elimination

    (13,604)

    (13,457)

    (14,084)

     

    (27,688)

    (24,982)

    Total net sales

    $901,000

    $692,489

    $922,396

     

    $1,823,396

    $1,342,135

     

    Three months ended

     

    Six months ended

    Segment profit

    July 1, 2023

    July 2, 2022

    April 1, 2023

     

    July 1, 2023

    July 2, 2022

    Specialty Chemicals and Engineered Materials

    $173,319

    $35,539

    $3,268

     

    $176,587

    $73,231

    Advanced Planarization Solutions

    42,419

    10,179

    (32,790)

     

    9,629

    21,338

    Microcontamination Control

    100,661

    100,107

    95,997

     

    196,658

    198,725

    Advanced Materials Handling

    35,830

    46,926

    48,165

     

    83,995

    93,616

    Total segment profit

    352,229

    192,751

    114,640

     

    466,869

    386,910

    Amortization of intangibles

    54,680

    12,494

    57,574

     

    112,254

    25,145

    Unallocated expenses

    29,935

    22,287

    43,600

     

    73,535

    40,449

    Total operating income

    $267,614

    $157,970

    $13,466

     

    $281,080

    $321,316

     

    Entegris, Inc. and Subsidiaries

    Reconciliation of GAAP Gross Profit to Adjusted Gross Profit

    (In thousands)

     

     

    Three months ended

     

    Six months ended

     

    July 1, 2023

    July 2, 2022

    April 1, 2023

     

    July 1, 2023

    July 2, 2022

    Net Sales

    $901,000

    $692,489

    $922,396

     

    $1,823,396

    $1,342,135

    Gross profit-GAAP

    $384,166

    $310,397

    $401,685

    $785,851

    $620,217

    Adjustments to gross profit:

     

     

     

     

     

     

    Restructuring costs 1

    7,377

     

    7,377

    Adjusted gross profit

    $384,166

    $310,397

    $409,062

     

    $793,228

    $620,217

     

     

     

     

     

     

     

    Gross margin - as a % of net sales

    42.6 %

    44.8 %

    43.5 %

     

    43.1 %

    46.2 %

    Adjusted gross margin - as a % of net sales

    42.6 %

    44.8 %

    44.3 %

     

    43.5 %

    46.2 %

     

    1 Restructuring charges resulting from cost saving initiatives.

     

    Entegris, Inc. and Subsidiaries

    Reconciliation of GAAP Segment Profit to Adjusted Operating Income

    (In thousands)

    (Unaudited)

     

     

    Three months ended

     

    Six months ended

    Adjusted segment profit

    July 1, 2023

    July 2, 2022

    April 1, 2023

     

    July 1, 2023

    July 2, 2022

    SCEM segment profit

    $173,319

    $35,539

    $3,268

     

    $176,587

    $73,231

    Restructuring costs 1

    6,523

     

    6,523

    Loss from the sale of QED and held for sales assets of EC 2

    1,304

    13,642

     

    14,946

    Gain on termination of alliance agreement4

    (154,754)

     

    (154,754)

    SCEM adjusted segment profit

    $19,869

    $35,539

    $23,433

     

    $43,302

    $73,231

     

     

     

     

     

     

     

    APS segment profit

    $42,419

    $10,179

    $(32,790)

     

    $9,629

    21,338

    Goodwill impairment 3

    88,872

     

    88,872

    Restructuring costs 1

    585

     

    585

    Loss from the sale of QED and held for sales assets of EC 2

    13,632

     

    13,632

    APS adjusted segment profit

    $56,051

    $10,179

    $56,667

     

    $112,718

    $21,338

     

     

     

     

     

     

     

    MC segment profit

    $100,661

    $100,107

    $95,997

     

    $196,658

    $198,725

    Restructuring costs 1

    2,795

     

    2,795

    MC adjusted segment profit

    $100,661

    $100,107

    $98,792

     

    $199,453

    $198,725

     

     

     

     

     

     

     

    AMH segment profit

    $35,830

    $46,926

    $48,165

     

    $83,995

    $93,616

    Restructuring costs 1

    1,254

     

    1,254

    AMH adjusted segment profit

    $35,830

    $46,926

    $49,419

     

    $85,249

    $93,616

     

     

     

     

     

     

     

    Unallocated general and administrative expenses

    $29,935

    $22,287

    $43,600

     

    $73,535

    $40,449

    Less: unallocated deal and integration costs

    (18,441)

    (12,575)

    (19,975)

     

    (38,416)

    (18,829)

    Less: unallocated restructuring costs 1

    (86)

     

    (86)

    Adjusted unallocated general and administrative expenses

    $11,494

    $9,712

    $23,539

     

    $35,033

    $21,620

     

     

     

     

     

     

     

    Total adjusted segment profit

    $212,411

    $192,751

    $228,311

     

    $440,722

    $386,910

    Less: adjusted unallocated general and administrative expenses

    11,494

    9,712

    23,539

     

    35,033

    21,620

    Total adjusted operating income

    $200,917

    $183,039

    $204,772

     

    $405,689

    $365,290

     

    1 Restructuring charges resulting from cost saving initiatives.

    2 Loss from the sale of QED and held for sales assets of EC.

    3 Non-cash impairment charges associated with goodwill.

    4 Gain on termination of alliance agreement with MacDermid Enthone.

     

    Entegris, Inc. and Subsidiaries

    Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA

    (In thousands)

    (Unaudited)

     

     

    Three months ended

     

    Six months ended

     

    July 1, 2023

    July 2, 2022

    April 1, 2023

     

    July 1, 2023

    July 2, 2022

    Net sales

    $901,000

    $692,489

    $922,396

     

    $1,823,396

    $1,342,135

    Net income (loss)

    $197,646

    $99,491

    $(88,166)

     

    $109,480

    $225,196

    Net income (loss) - as a % of net sales

    21.9%

    14.4%

    (9.6%)

     

    6.0%

    16.8%

    Adjustments to net income (loss):

     

     

     

     

     

     

    Equity in net loss of affiliates

    130

     

    130

    Income tax (benefit) expense

    (16,491)

    17,517

    21,469

     

    4,978

    37,392

    Interest expense, net

    78,605

    31,343

    84,821

     

    163,426

    44,877

    Other expense (income), net

    7,724

    9,619

    (4,658)

     

    3,066

    14,521

    GAAP - Operating income

    267,614

    157,970

    13,466

     

    281,080

    321,316

    Operating margin - as a % of net sales

    29.7%

    22.8%

    1.5%

     

    15.4%

    23.9%

    Goodwill Impairment 1

    88,872

     

    88,872

    Deal and transaction costs 2

    2,410

    3,001

     

    3,001

    7,418

    Integration costs:

     

     

     

     

     

     

    Professional fees 3

    13,324

    9,525

    11,988

     

    25,312

    10,321

    Severance costs 4

    965

    1,362

     

    2,327

    Retention costs 5

    362

    1,280

     

    1,642

    Other costs 6

    3,789

    640

    2,345

     

    6,134

    1,090

    Restructuring costs 7

    11,242

     

    11,242

    Loss on sale of business and held for sale assets 8

    14,937

    13,642

     

    28,579

    Gain on termination of alliance agreement 9

    (154,754)

     

    (154,754)

    Amortization of intangible assets 10

    54,680

    12,494

    57,574

     

    112,254

    25,145

    Adjusted operating income

    200,917

    183,039

    204,772

     

    405,689

    365,290

    Adjusted operating margin - as a % of net sales

    22.3%

    26.4%

    22.2%

     

    22.2%

    27.2%

    Depreciation

    43,719

    24,381

    46,775

     

    90,494

    48,286

    Adjusted EBITDA

    $244,636

    $207,420

    $251,547

     

    $496,183

    $413,576

    Adjusted EBITDA - as a % of net sales

    27.2%

    30.0%

    27.3%

     

    27.2%

    30.8%

     

    1 Non-cash impairment charges associated with goodwill.

    2 Deal and transaction costs associated the CMC acquisition and completed and announced divestitures.

    3 Represents professional and vendor fees recorded in connection with services provided by consultants, accountants, lawyers and other vendors to assist us in integrating the recently acquired CMC into our operations. These fees arise outside of the ordinary course of our continuing operations.

    4 Represent severance charges resulting from cost saving initiatives in connection with the CMC acquisition.

    5 Represents retention charges related directly to the CMC acquisition and completed and announced divestitures, and are not part of our normal, recurring cash operating expenses.

    6 Represents other employee related costs and other costs incurred relating to the CMC acquisition and the completed and announced divestitures. These costs arise outside of the ordinary course of our continuing operations.

    7 Restructuring charges resulting from cost saving initiatives.

    8 Loss from the sale of QED and held for sales assets of EC.

    9 Gain on termination of alliance agreement with MacDermid Enthone.

    10 Non-cash amortization expense associated with intangibles acquired in acquisitions.

     

    Entegris, Inc. and Subsidiaries

    Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted Non-GAAP Earnings per Common Share

    (In thousands, except per share data)(Unaudited)

     

     

    Three months ended

     

    Six months ended

     

    July 1, 2023

    July 2, 2022

    April 1, 2023

     

    July 1, 2023

    July 2, 2022

    GAAP net income (loss)

    $197,646

    $99,491

    $(88,166)

     

    $109,480

    $225,196

    Adjustments to net income (loss):

     

     

     

     

     

     

    Goodwill Impairment 1

    88,872

     

    88,872

    Deal and transaction costs 2

    2,410

    3,001

     

    3,001

    7,418

    Integration costs:

     

     

     

     

     

     

    Professional fees 3

    13,324

    9,525

    11,988

     

    25,312

    10,321

    Severance costs 4

    965

    1,362

     

    2,327

    Retention costs 5

    362

    1,280

     

    1,642

    Other costs 6

    3,789

    640

    2,345

     

    6,134

    1,090

    Restructuring costs 7

    11,242

     

    11,242

    Loss on extinguishment of debt and modification 8

    4,481

    3,880

     

    8,361

    Loss on sale of business and held for sale assets9

    14,937

    13,642

     

    28,579

    Infineum termination fee, net 10

    (10,877)

     

    (10,877)

    Interest expense, net 11

    22,742

     

    27,425

    Amortization of intangible assets 12

    54,680

    12,494

    57,574

     

    112,254

    25,145

    Gain on termination of alliance agreement 13

    (154,754)

     

    (154,754)

    Tax effect of adjustments to net income (loss) and discrete items14

    (35,825)

    (10,486)

    1,639

     

    (34,186)

    (14,646)

    Non-GAAP net income

    $99,605

    $136,816

    $97,782

     

    $197,387

    $281,949

     

     

     

     

     

     

     

    Diluted earnings (loss) per common share

    $1.31

    $0.73

    $(0.59)

     

    $0.73

    $1.65

    Effect of adjustments to net income (loss)

    $(0.65)

    $0.27

    $1.26

     

    $0.58

    $0.42

    Diluted non-GAAP earnings per common share

    $0.66

    $1.00

    $0.65

     

    $1.31

    $2.07

     

     

     

     

     

     

     

    Diluted weighted averages shares outstanding

    150,837

    136,454

    149,426

     

    150,609

    136,503

    Effect of adjustment to diluted weighted average shares

    955

     

    Diluted non-GAAP weighted average shares outstanding

    150,837

    136,454

    150,381

     

    150,609

    136,503

     

    1 Non-cash impairment charges associated with goodwill.

    2 Deal and transaction costs associated with the CMC acquisition and completed and announced divestitures.

    3 Represents professional and vendor fees recorded in connection with services provided by consultants, accountants, lawyers and other vendors to assist us in integrating the recently acquired CMC into our operations. These fees arise outside of the ordinary course of our continuing operations.

    4 Represent severance charges resulting from cost saving initiatives from the CMC acquisition.

    5 Represents retention charges related directly to the CMC acquisition and completed and announced divestitures, and are not part of our normal, recurring cash operating expenses.

    6 Represents other employee related costs and other costs incurred relating to the CMC acquisition and completed and announced divestitures. These costs arise outside of the ordinary course of our continuing operations.

    7 Restructuring charges resulting from cost saving initiatives.

    8 Non-recurring loss on extinguishment of debt and modification of our Credit Amendment.

    9 Loss from the sale of QED and held for sales assets of EC.

    10 Non-recurring gain from the termination fee with Infineum.

    11 Non-recurring interest costs related to the financing of the CMC acquisition.

    12 Non-cash amortization expense associated with intangibles acquired in acquisitions.

    13 Gain on termination of alliance agreement with MacDermid Enthone.

    14 Tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years.

     

    Entegris, Inc. and Subsidiaries

    Reconciliation of GAAP Outlook to Non-GAAP Outlook

    (In millions, except per share data)

    (Unaudited)

     

     

    Third-Quarter Outlook

    Reconciliation GAAP Operating Margin to non-GAAP Operating Margin and Adjusted EBITDA Margin

    September 30,2023

    Net sales

    $875 - $900

    GAAP - Operating income

    $118 - $133

    Operating margin - as a % of net sales

    13% - 15%

    Deal, transaction and integration costs

    12

    Amortization of intangible assets

    51

    Adjusted operating income

    $181 - $196

    Adjusted operating margin - as a % of net sales

    21% - 22%

    Depreciation

    47

    Adjusted EBITDA

    $228 - $243

    Adjusted EBITDA - as a % of net sales

    26% - 27%

     

    Third-Quarter Outlook

    Reconciliation GAAP net income to non-GAAP net income

    September 30,2023

    GAAP net income

    $34 - $42

    Adjustments to net income:

     

    Deal, transaction and integration costs

    12

    Amortization of intangible assets

    51

    Income tax effect

    (11)

    Non-GAAP net income

    $86 - $94

     

    Third-Quarter Outlook

    Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share

    September 30,2023

    Diluted earnings per common share

    $0.23 - $0.28

    Adjustments to diluted earnings per common share:

     

    Deal, transaction and integration costs

    0.09

    Amortization of intangible assets

    0.34

    Income tax effect

    (0.09)

    Diluted non-GAAP earnings per common share

    $0.57 - $0.62

     

    Entegris, Inc. and Subsidiaries

    Reconciliation of Proforma Sales to Proforma Non-GAAP Net Sales

    (In thousands)

    (Unaudited)

     

     

    Three months ended

    Six months ended

     

    July 1, 2022

    April 1, 2022

    July 1, 2022

    Proforma Net Sales 1

    $1,011,862

    $969,091

    $1,980,953

    Less: Wood treatment 2

    (200)

    (10,907)

    (11,107)

    Proforma Net Sales - Non GAAP

    $1,011,662

    $958,184

    $1,969,846

     

    1 The above pro forma results include the addition of CMC Materials, Inc.’s financials recorded prior to the consummation of the merger with the Company on July 6, 2022 to the Company’s reported financials and are provided as a complement to, and should be read in conjunction with, the consolidated financial statements to better facilitate the assessment and measurement of the Company’s operating performance. Intercompany sales between the Company and CMC Materials, Inc have been eliminated. No other adjustments have been included.

     

    2 The adjustment relates to removal of net sales related to CMC’s wood treatment business. Prior to the acquisition, CMC operated a wood treatment business, which manufactured and sold wood treatment preservatives for utility poles and crossarms. CMC exited this business during the first half of 2022, prior to our acquisition of CMC. The wood treatment business had no ongoing sales at the time of acquisition and removed for comparable purposes.

     


    The Entegris Stock at the time of publication of the news with a fall of -2,92 % to 96,25EUR on Tradegate stock exchange (02. August 2023, 22:26 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Entegris Reports Results for Second Quarter of 2023 Entegris, Inc. (NASDAQ: ENTG), today reported its financial results for the Company’s second quarter ended July 1, 2023. Second-quarter sales were $901.0 million, an increase of 30% from the same quarter last year. Second-quarter GAAP net income was …